The central analgesic and anti-inflammatory activities of the methanolic extract of Carthamus oxycantha

Journal of Physiology and Pharmacology

Volumn 64, Issue 3, 2013, Pages

  Bukhari, Ishfaq A ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Analgesic activity; Anti inflammatory activity; Carthamus oxycantha; Edema; Nociception; Pain; Plant extract; Rodents

Indexed keywords

ACETIC ACID; ACETIC ACID ETHYL ESTER; ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; CARRAGEENAN; CARTHAMUS OXYCANTHA EXTRACT; DICLOFENAC; FORMALDEHYDE; HEXANE; METHANOL; MORPHINE; NALOXONE; PLANT EXTRACT; UNCLASSIFIED DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; SOLVENT;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARTHAMUS; CARTHAMUS OXYCANTHA; CONTROLLED STUDY; DOSE RESPONSE; DROWSINESS; DRUG SCREENING; FLOWER; HOT PLATE TEST; LATENT PERIOD; LD 50; LICKING; MALE; MOTOR DYSFUNCTION; MOUSE; NOCICEPTION; NONHUMAN; PAIN; PAIN THRESHOLD; PAW EDEMA; PLANT LEAF; PLANT ROOT; RAT; WRITHING TEST; ANIMAL; ANIMAL BEHAVIOR; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECTS; ETHNOPHARMACOLOGY; INBRED MOUSE STRAIN; PAKISTAN; PHYTOTHERAPY; RANDOMIZATION; SPRAGUE DAWLEY RAT;

ANALGESICS, NON-NARCOTIC; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BEHAVIOR, ANIMAL; CARTHAMUS; ETHNOPHARMACOLOGY; FLOWERS; LETHAL DOSE 50; MALE; METHANOL; MICE; MICE, INBRED STRAINS; PAIN THRESHOLD; PAKISTAN; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES; PLANT ROOTS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SOLVENTS;

EID: 84895916175     PISSN: 08675910     EISSN: 18991505     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Baquar SR. Medicinal and poisonous plants of Pakistan. Karachi, Pakistan, Printas, 1989.
2. Ahmad M, Waheed I, Khalil-ur-Rehman M, Uzma Niaz U, Saeed-ul-Hassan S. A Review on Carthamus oxycantha. Pak J Pharm 2007; 1: 20-23.
3. Fernandez-Martinez M, Del-Rio M, de Haro A. Survey of safflower (Carthamus oxycantha L.) germplasm for variants in fatty acid composition and other seed characters. Euphytica 1993; 69: 115-122.
4. Anjani. Genetic variability and character association inwild safflower (Carthamus oxycantha). Indian J Agric Sci 2005; 75: 516-518.
5. Nadkarni KM. Indian materia medica. Bombay, India, Popular Prakashan, 1976.
6. Usmanghani K, Saeed A, Alam, MT. Indusyunic Medicine. University of Karachi Press, Karachi, 1997.
7. Asgarpanah J, Nastaran Kazemivash N. Phytochemistry, pharmacology and medicinal properties of Carthamus tinctorius L. Chin J Integr Med 2013; 2: 153-159.
8. Taskova R, Mitova M, Najdenski H, Tzvetkova I, Duddeck H. Antimicrobial activity and cytotoxicity of Carthamus lanatus. Fitoterapia 2002; 73: 540-543.
9. Gilani AH, Bukhari IA, Khan RA, Khan AU, Ullah F, Ahmad VU. Cholinomimetic and calcium channel blocking activities of Carthamus oxycantha. Phytother Res 2005; 19: 679-683.
10. Liu F, Wei Y, Yang XZ, Li FG, Hu J, Cheng RF. Hypotensive effects of safflower yellow in spontaneously hypertensive rats and influence on plasma renin activity and angiotensin II level. Yao Xue Xue Bao 1992; 27: 785-787.
11. Zhang HL, Nagatsu A, Watanabe T, Sakakibara J, Okuyama H. Antioxidative compounds isolated from safflower (Carthamus tinctorius) oil cake. Chem Pharm Bull 1997; 45: 1910-1914.
12. Meselhy MR, Kadota S, Momose Y, Hattori M, Namba T. Tinctormine, a novel Ca+2 antagonist N-containing quinochalcone C-glycoside fromCarthamus tinctorius. Chem Pharma Bull 1992; 40: 3355-3357.
13. Loo WT, Cheung MN, Chow LW. The inhibitory effect of a herbal formula comprising ginseng and Carthamus tinctorius on breast cancer. Life Sci 2004; 76: 191-204.
14. Bocheva A, Mikhova B, Taskova R, Mitova M, Duddeck H. Anti-inflammatory and analgesic effects of Carthamus lanatus aerial parts. Fitoterapia 2003; 74: 559-563.
15. Asgarpanah J, Kazemivash N. Phytochemistry, pharmacology and medicinal properties of Carthamus tinctorius L. Chin J Integr Med 2013; 19: 153-159.
16. Lee JY, Chang EJ, Kim HJ, Park JH, Choi SW. Antioxidative flavonoids from leaves of Carthamus tinctorius. Arch Pharm Res 2002; 25: 313-319.
17. Taskova R, Mitova M, Mikhova B, Duddeck H. Bioactive phenolics from Carthamus lanatus L. Z Naturforsch C 2003; 58: 704-707.
18. Hassan Z, Ahmad VU, Hussain J, et al. Two new carthamosides from Carthamus oxycantha. Nat Prod Commun 2010; 5: 419-22.
19. Koster R, Anderson M, de Beer EJ. Acetic acid for analgesic screening. Fed Proc 1959; 18: 412.
20. Hunskaar S, Hole K. The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain 1987; 30: 103-114.
21. Eddy NB, Leimback D. Synthetic analgesis II. Dithienylbutenyl and dithienylbutylamines. J Pharmacol Exp Ther 1953; 107: 385-393.
22. Winter CA, Risely EA, Nuss GW. Carrageenan induced edema in hind paw of the rat as an assay for anti-inflammatory drugs. Proc Soc Exp Biol Med 1962; 111: 544-547.
23. Kouadio F, Kanko C, Juge M, et al. Analgesic and antiinflammatory activities of an extract from Parkia biglobosa used in traditional medicine in the Ivory Coast. Phytother Res 2000; 14: 635-637.
24. Deraedt R, Jougney S, Delevalcee F, Falhout M. Release of prostaglandins E and F in an ilgogenic reaction and its inhibition. Eur J Pharmacol 1980; 51: 17-24.
25. Bentley GA, Newton SH, Starr J. Studies on the anti-nociceptive action of alpha-against drugs and their interaction with opioid mechanisms. Br J Pharmacol 1983; 79: 125-134.
26. Toma W, Gracioso JS, Hiruma-Lima CA, Andrade FD, Vilegas W, Souza Brito AR. Evaluation of the analgesic and antiedematogenic activities of Quassia amara bark extracts. J Ethnopharmacol 2003; 85: 19-23.
27. Nwafor PA, Okwuasaba FK. Anti-nociceptive and anti-inflammatory effects of methanolic extract of Asparagus pubescens root in rodents. J Ethnopharmacol 2003; 84: 125-129.
28. Sulaiman MR, Somchit MN, Israf DA, Ahmad Z, Moin S. Antinociceptive effect of Melastoma malabathricum ethanolic extract in mice. Fitoterapia 2004; 75: 667-672.
29. Vogel GH, Vogel WH. Analgesic, anti-inflammatory, and anti-pyretic activity. In: Drug Discovery and Evaluation. Pharmacological Assays 360, Springer, 1997, pp. 360-418.
30. Collier HO, Dinnen LC, Johnson CA, Schneide C. Abdominal constrictions response and its suppression by analgesic drugs in mouse. Br J Pharmacol 1968; 32: 265-268.
31. Tjolsen A, Berge OG, Hunskaar S, Rosland JH, Hole K. The formalin test: an evaluation of the method. Pain 1992; 51: 5-17.
32. Murray CW, Porreca F, Cowan A. Methodological refinements to the mouse paw formalin test. An animal model of tonic pain. J Pharmacol Methods 1988; 20: 175-186.
33. Shibata M, Ohkubo T, Takahashi H, Inoki R. Modified formalin test: characteristics biphasic pain response. Pain 1989; 38: 347-352.
34. Santos AR, Filho VC, Niero R, et al. Analgesic effect of Callus culture extracts from selected species of Phyllanthus in mice. J Pharm Pharmacol 1994; 46: 755-759.
35. Mohsin A, Shah AH, Al-Yahya MA, Tariq M, Tanira MO, Ageel AM. Analgesic, anti-pyretic activity and phystochemical screening of some plants used traditional Arab system of medicine. Fitoterapia 1989; 60: 174-177.
36. Almeida RN, Navarro DS, Barbosa-Filho JM. Plants with central analgesic activity. Phytomedicine 2001; 8: 310-322.
37. Lopez-Lazaro M. Distribution and biological activities of the flavonoid luteolin. Mini Rev Med Chem 2009; 9: 31-59.
38. Nassar MI, Aboutabl el-SA, Eskander DM, Grace MH, El-Khrisy ED, Sleem AA. Flavonoid glycosides and pharmacological activity of Amphilophium paniculatum. Pharmacognosy Res 2013; 5: 17-21.
39. Ramesh T, Sureka C, Bhuvana S, Hazeena Begum V. Sesbania grandiflora diminishes oxidative stress and ameliorates antioxidant capacity in liver and kidney of rats exposed to cigarette smoke. J Physiol Pharmacol 2010; 61: 467-476.
40. Turner RA. Screening Methods in Pharmacology. New York, Academic Press, 1965.
41. Parkhouse J, Pleuvry BJ. Analgesic Drugs. Oxford, Black, 1979.
42. Zurowski D, Nowak L, Machowska A, Wordliczek J, Thor PJ. Exogenous melatonin abolishes mechanical allodynia but not thermal hyperalgesia in neuropathic pain. The role of the opioid system and benzodiazepine-gabaergic mechanism. J Physiol Pharmacol 2012; 63: 641-647.
43. Di Rosa M, Giroud JP, Willoughby DA. Studies on the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine. J Pathol 1971; 104: 15-29.
44. Burch RM, DeHaas C. A bradykinin antagonist inhibits carrageenan edema in rats. Naunyn Schmiedebergs Arch Pharmacol 1990; 342: 189-193.
45. Di Rosa M. Biological properties of carrageenan. J Pharm Pharmacol 1972: 24: 89-102.
46. Della Loggia R, Tubaro A, Dri P, Zilli C, Del Negro P. The role of flavonoids in the antiinflammatory activity of Chamomilla recutita. Prog Clin Biol Res 1986; 213: 481-484.
47. Saeed SA, Simjee RU, Shamim G, Gilani AH. Eugenol: a dual inhibitor of platelet activating factor and arachidonic acid metabolism. Phytomedicine 1995; 2: 23-28, 1995.
48. Mesia-Vela S, Souccar C, Lima-Landman MT, Lapa AJ. Pharmacological study of Stachytarpheta cayennensis Vahl in rodents. Phytomedicine 2004; 11: 616-624.
49. Ozaki Y, Xing L, Satake M. Antiinflammatory effect of Trichosanthes kirilowii Maxim, and its effective parts. Bio Pharma Bull 1996; 19: 1046-1048.
50. Devi BP, Boominathan R, Mandal SC. Anti-inflammatory, analgesic and antipyretic properties of Clitoria ternatea root. Fitoterapia 2003; 74: 345-349.
51. Menasse R, Hedwall PR, Kraetz J, et al. Pharmacological properties of diclofenac sodium and its metabolites. Scand J Rheumatol 1978; 22: 5-16.
52. Al-Tuwaijri AS, Mustafa AA. Verapamil enhances the inhibitory effect of diclofenac on the chemiluminescence of human polymorphonuclear leukocytes and carrageenan-induced rat's paw edema. Int J Immunopharmacol 1992; 14: 83-91.
53. Mahgoub AA. Grapefruit juice potentiates the anti-inflammatory effects of diclofenac on the carrageenan-induced rat's paw oedema. Pharmacol Res 2002; 45: 1-4.
54. Meckes M, David-Rivera AD, Nava-Aguilar V, Jimenez A. Activity of some Mexican medicinal plant extracts on carrageenan-induced rat paw edema. Phytomedicine 2004; 11: 446-451.
55. Skoutakis VA, Carter CA, Mickle TR, et al. Review of diclofenac and evaluation of its place in therapy as a nonsteroidal antiinflammatory agent. Drug Intell Clin Pharm 1988; 22: 850-859.
56. Levine J, Taiwo Y. Inflammatory pain. In: Textbook of Pain, PD Wall, R Melzack (eds), New York, Churchill Livingstone, 1994, pp. 45-56.
57. Chen YF, Tsai HY, Wu TS. Anti-inflammatory and analgesic activities from roots of Angelica pubescens. Planta Med 1995; 61: 2-8.
58. Hassan Z, Hussain H, Ahmad VU, et al. Absolute configuration of 1b, 10b-epoxydesacetoxymatricarin isolated from Carthamus oxycanthaby means of TDDFT CD calculations. Tetrahedron Asymmetry 2007; 18: 2905-2909.
59. Vane JR. The fight against rheumatism: from willow bark to COX-1 sparing drugs. J Physiol Pharmacol 2000; 51: 573-586.